Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Cytochroma Inc. is an integrated specialty pharmaceutical company engaged in the development and commercialization of proprietary products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. The company has an advanced portfolio of new products targeting vitamin D deficiency and secondary hyperparathyroidism in patients with moderate to severe chronic kidney disease and end stage renal disease. In addition, the company is developing novel vitamin D therapies to treat hyperproliferative disorders such as cancer and psoriasis. Cytochroma is a privately held company with offices in Markham, Ontario and Madison, Wisconsin. ( www.cytochroma.com )
Cytochroma Inc.
330 Cochrane Drive
Markham, Ontario L3R 8E4
Canada
Tel: (905) 479-5306
Fax: (905) 479-1287